• Nektar Therapeutics

455 Mission Bay Boulevard South
San Francisco, CA 94158
United States
Website

More+

Nektar Therapeutics

NKTR

Price

Last Close
$ 16.51 ( +0.08 )
Trading Volume
462,300
Market Cap
$ 2.9B
52-Week High/Low
$15.74 - $25.46

Earnings

2020 2021
$ 0 $ 0
P/E Ratio
Trailing Forward
$ 0 -
2020 P/E Ratio
Trailing Forward
$ 0 -
2020 P/E Ratio
Trailing Forward
$ 0 $ -

Gain

30-day
NKTR -34%
S&P 500 3.47%
90-day
-16.11%
5.48%

180-day

-6.93%
14.72%

52-Week

-28.47%
37.2%

Dividend

Dividend
$0
Dividend Yield
0%
Outstanding
174,104,000
50 Day Avg Volume
800299

Calendar

Fiscal Year End
Dec 31
Last Earning Date
Mar 01, 2017
Ex-Dividend Date
Jun 11, 2014
Current Year Beta
0.58

Ratio

Debt to Equity
0.14
Return on Equity
39.67
Price to Cash Flow
-

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 - -16.2% 2.2% 77.9% 91.3% -18.4% -29% 6.8% 48.5% 41.4% -
Q2 - 29.8% 3.6% -50.6% -16.7% 3.5% 13.7% 5.8% 7% 3.7% -
Q3 - -28.4% -49.7% 24.8% 22.8% 20.7% -12.4% -5.9% -12.6% 30.4% -
Q4 - 2.5% 17.1% -42% 141.1% -28.6% 53.7% 28.4% 8.6% -30.6% -

Returns +
M

J F M A M J J A S O N D
2021 - - - - - - - - - - - -
2020 -6.58% 0.05% -10.3% 7.56% 13.02% 6.73% -4.32% -13.13% -13.82% -4.52% 3.47% 3.72%

Returns +
A

    2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
    -3%-20%-35%-45%387%-27%9%37%53%32%-56%

52 Week High/Low

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 - - 0.68 0.60 0.42 0.14 0.25 -0.37 -0.48 -0.36
Q2 - - 0.63 5.33 0.39 0.36 0.40 -0.26 -0.37 -0.30
Q3 - - 0.56 0.56 0.37 0.32 0.06 0.53 -0.14 -0.38
Q4 - - 0.64 0.57 0.14 0.28 0.40 -0.32 -0.41 -0.46
A - - 2.5100000000000002 7.06 1.3200000000000003 1.1 1.1099999999999999 -0.42 -1.40 -1.50

Dividend +

Q1
Q2
Q3
Q4
A

Chart +